scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41374-019-0342-6 |
P698 | PubMed publication ID | 31745210 |
P2093 | author name string | Feng Liu | |
Xiaoxiao Wang | |||
Lai Wei | |||
Chaodong Wu | |||
Rui Huang | |||
Xiaohe Li | |||
Huiying Rao | |||
Ran Fei | |||
Jingmin Zhao | |||
Aileen Wee | |||
P2860 | cites work | STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling | Q24336398 |
Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation | Q28256216 | ||
Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis | Q30238749 | ||
Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. | Q30375131 | ||
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. | Q30596736 | ||
Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans | Q34159110 | ||
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease | Q34540703 | ||
Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection | Q35358973 | ||
Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children | Q36791363 | ||
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies | Q36870030 | ||
STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. | Q37236401 | ||
STING-dependent cytosolic DNA sensing pathways | Q38169005 | ||
Macrophage heterogeneity in liver injury and fibrosis | Q38177568 | ||
The immunophenotype of antigen presenting cells of the mononuclear phagocyte system in normal human liver--a systematic review | Q38260237 | ||
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. | Q38680300 | ||
STING-IRF3 Triggers Endothelial Inflammation in Response to Free Fatty Acid-Induced Mitochondrial Damage in Diet-Induced Obesity | Q38711931 | ||
Positive feedback regulation of type I interferon by the interferon-stimulated gene STING. | Q38921904 | ||
The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications. | Q39099711 | ||
Targeting hepatic macrophages to treat liver diseases | Q39166232 | ||
Liver macrophages in tissue homeostasis and disease | Q39187324 | ||
The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease | Q39311652 | ||
Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection | Q40696672 | ||
Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts | Q40852538 | ||
Arginase 2 deficiency results in spontaneous steatohepatitis: a novel link between innate immune activation and hepatic de novo lipogenesis | Q42111412 | ||
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention | Q45067817 | ||
Therapeutic Inhibition of Inflammatory Monocyte Recruitment Reduces Steatohepatitis and Liver Fibrosis | Q45872331 | ||
Lipotoxicity induces hepatic protein inclusions through TBK1-mediated p62/SQSTM1 phosphorylation | Q47281872 | ||
cGAS-mediated autophagy protects the liver from ischemia/reperfusion injury independent of STING. | Q49986890 | ||
Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease. | Q50139495 | ||
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. | Q50528458 | ||
Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis. | Q51062671 | ||
Endoplasmic Reticulum Stress-induced Hepatocellular Death Pathways Mediate Liver Injury and Fibrosis via Stimulator of Interferon Genes. | Q51346281 | ||
Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury. | Q51702513 | ||
STING dependent sensing - Does HIV actually care? | Q52352448 | ||
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease. | Q52873745 | ||
CD163L1 and CLEC5A discriminate subsets of human resident and inflammatory macrophages in vivo. | Q53543419 | ||
Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma. | Q54419476 | ||
Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 | Q56379571 | ||
Mechanisms of NAFLD development and therapeutic strategies. | Q59443140 | ||
Secretory leukocyte protease inhibitor: A pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure | Q60713404 | ||
Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis | Q62735118 | ||
Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease | Q89235898 | ||
STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis | Q90609055 | ||
Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice | Q91433764 | ||
P433 | issue | 4 | |
P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
fatty liver disease | Q6058862 | ||
bites and stings | Q54911704 | ||
P304 | page(s) | 542-552 | |
P577 | publication date | 2019-11-19 | |
P1433 | published in | Laboratory Investigation | Q6467260 |
P1476 | title | STING expression in monocyte-derived macrophages is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease | |
P478 | volume | 100 |
Q99629093 | Nrf2 mitigates prolonged PM2.5 exposure-triggered liver inflammation by positively regulating SIKE activity: Protection by Juglanin | cites work | P2860 |
Search more.